Therapeutic Drug Monitoring in Patients With Ulcers

Abstract

Get full access to this article

View all access options for this article.

References

McCarthy DM : Using H2-antagonist drugs. Drug Ther 18:21-33, 1988

Press release: The Health Strategy Group. New York, NY , 1985

Jensen DM : Economic and health aspects of peptic ulcer disease and H2-receptors antagonists . Am J Med 81:42-48, 1986 (suppl B)

Peterson WL , Sturdevant RL , Frankel HD , et al: Healing of duodenal ulcer with an antacid regimen. N Engl J Med 297:341-345, 1977

Lam I. : Treatment of duodenal ulcer with antacid and sulpride. Gastroenterology 76:315-320, 1979

Bianchi PG , Parente F. , Lazzaroni M. , et al: Medium dose-antacids versus cimetidine in short term treatment of doudenal ulcer. J Clin Gastroenterol 8:141-145, 1986

Ippoliti AF , Sturdevant RL : Cimetidine versus intensive antacid therapy for peptic ulcer disease . Gastroenterology 74:391-395, 1978

Dal Negro R. : Famotidine and theophylline: A cimetidine like pharmacokinetic interaction . Ital J Chest Dis 42:185-186, 1988

Nagazawa S. , Nagashima R. , Samlof IM : Selective binding of sucralfate to gastric ulcer in man. Dig Dis Sci 26:297-300, 1981

10.

Hollander D. : Efficacy of sucralfate for duodenal ulcers: A multicentered, doubleblind trial. J Clin Gastroenterol 3:153-157, 1981 (suppl 2)

11.

Marks IN , Lucke W. , Wright JP , et al: Ulcer healing and relapse rates after treatment with cimetidine or sucralfate. J Clin Gastroenterol 3:163-165, 1981 (suppl 2)

12.

Brandstaetter G. , Kratpchvil P. : Comparison of two sucralfate dosages (2 g twice a day versus lg four times daily) in duodenal ulcer healing. Am J Med 79:36-38, 1985 (suppl 2C)

13.

Van Deventer GM , Schneidman D. , Walsh JH : Sucralfate and cimetidine as single agents and in combination for treatment of active duodenal ulcers, a double-blind placebo control trial. Am J Med 79:39-44, 1985 (suppl 2c)

14.

Freidman GD , Siegelaub AB , Seltzer CC : Cigarettes, alcohol, coffee and peptic ulcer . N Engl J Med 290:469-473, 1974

15.

Scharschmidt BF : Peptic ulcer disease-Pathophysiology and current medical management [Medical Staff Conference]. West J Med 146:724-733, 1987

16.

Shulman ES , McKenzie CA , Graham L. : How H2Antagonists have changed ulcer therapy. US Pharm 7:53-70,1989

17.

Bettarello A. : Anti-ulcer therapy. Past to present. Dig Dis Sci 30:36-42, 1985 (suppl 11)

18.

Simonsen LL : New prescription volume increases 4.2% moving total rxs up 1.4%. Pharm Times 54:38-46, 1988

19.

Armstrong CP , Blower AL : Non-steroidal antiinflammatory drugs and life threatening complications of peptic ulceration. Gut 28:527-532, 1987

20.

Carson JL , Strom BL , Soper KA , et al: The association of nonsteroidal anti-inflammatory drugs with upper gastrointestinal tract bleeding. Arch Intern Med 147:85-88, 1987

21.

Ivey KJ : Mechanisms of nonsteroidal anti-inflammatory drug-induced gastric damage. Am J Med 84:41-48, 1988 (suppl 2a)

22.

Graham DY : Prevention of gastroduodenal injury induced by chronic nonsteroidal antiinflammatory drug therapy. Gastroenterology 96:675-681, 1989

23.

Roth SH , Bennett RE : Nonsteroidal anti-inflammatory drug gastropathy. Arch Intern Med 147:2093-2100, 1987

24.

Collier DJ , Pain JA : Non-steroidal anti-inflammatory drugs and peptic ulcer perforation . Gut 26:359-363, 1985

25.

Caruso I. , Porro GB : Gastroscopic evaluation of antiinflammatory agents. Br Med J 1:75-78, 1980

26.

Carson JL , Strom BL , Morse ML , et al: The relative gastrointestinal toxicity of the nonsteroidal anti-inflammatory drugs. Arch Intern Med 147:1054-1059,1987

27.

Aadland E. , Fausa O. , Vatn M. , et al: Protection by misoprostol against naproxen-induced gastric mucosal damage. Am J Med 83:37-40,1987 (suppl 1a)

28.

Lanza FL : A double-blind study of prophylactic effect of misoprostol on lesions of gastric and duodenal mucosa induced by oral administration of tolmetin in healthy subjects. Dig Dis Sci 31:131-136, 1986 (suppl)

29.

Jiranek GC , Kimmey MB , Saunders DR , et al: Misoprostol reduces gastroduodenal injury from one week of aspirin: An endoscopic study. Gastroenterology 96:656-661, 1989

30.

Lanza FL , Aspinall RL , Swabb EA , et al: Doubleblind, placebo-controlled endoscopic comparison of the mucosal protective effects of misoprostal versus cimetidine on tolmetin-induced mucosal injury to the stomach and duodenum. Gastroenterology 95:294-298, 1988

31.

Graham DY , Agrawal NM , Roth SH : Prevention of NSAID-induced gastric ulcer with misoprostol: Multicentre, double-blind, placebo-controlled trial. Lancet 2:1277-1280, 1988

32.

Wildeman RA : Focus on misoprostol: Review of worldwide safety data. Clin Invest Med 10:243-245, 1987

33.

Anonymous: Misoprostol. Med Lett Drugs Ther 31:21-22, 1989

34.

Semble EL , Wu WC : Antiinflammatory drugs and gastric mucosal damage. Semin Arthritis Rheum 16:271-286, 1987

35.

American Hospital Formulary Service, Drug Information 1989 . Washington, DC, American Society of Hospital Pharmacists , 1989, p 1668

36.

O'Laughlin JC , Silvoso GR , Ivey KJ : Healing of aspirin-associated peptic ulcer disease despite continued salicylate ingestion. Arch Intern Med 141:781-783, 1981

37.

Manniche C. , Malchow-Moller A. , Andersen JR , et al: Randomized study of the influence of non-steroidal antiinflammatory drugs on the treatment of peptic ulcer in patients with rheumatic disease. Gut 28:226-229, 1987

38.

Lucas CE , Sugawa C. , Riddle J. , et al: Natural history and surgical dilemma of "stress" gastric bleeding . Arch Surg 102:266-273, 1971

39.

Skillman JJ , Bushnell LS , Goldman H. , et al: Respiratory failure, hypotension, sepsis, and jaundice. Am J Surg 117:523-530, 1969

40.

Schuster DP , Rowley H. , Feinstein S. , et al: Prospective evaluation of the risk of upper gastrointestinal bleeding after admission to a medical intensive care unit. Am J Med 76:623-629, 1984

41.

Hastings PR , Skillman JJ , Bushnell LS , et al: Antacid titration in the prevention of acute gastrointestinal bleeding. N Engl J Med 298:1041-1045,1978

42.

Priebe HJ , Skillman JJ , Bushnell LS , et al: Antacid versus cimetidine in preventing acute gastrointestinal bleeding. N Engl J Med 302:426-430, 1980

43.

Czaja AJ , McAlhany JC , Pruitt BA : Acute gastroduodenal disease after thermal injury. N Engl J Med 291:925-929, 1974

44.

Shuman RB , Shuster DP , Zuckerman GR : Prophylactic therapy for stress ulcer bleeding: A reappraisal. Ann Intern Med 106:562-567, 1987

45.

Anderberg B. , Sjodahl R. : Prophylaxis and management of stress ulcers . Scand J Gastroenterol 20:101-104, 1985 (suppl 110)

46.

Borrero E. , Ciervo J. , Chang JB : Antacid vs sucralfate in preventing acute gastrointestinal tract bleeding in abdominal aortic surgery. Arch Surg 121:810-812, 1986

47.

Borrero E. , Margolis IB , Bank S. , et al: Antacid versus sucralfate in preventing acute gastrointestinal bleeding. Am J Surg 148:809-812, 1984

48.

Borrero E. , Bank S. , Margolis I. , et al: Comparison of antacid and sucralfate in the prevention of gastrointestinal bleeding in patients who are critically ill. Am J Med 79:62-64, 1985 (suppl 2c)

49.

Stothert JC , Simonowitz DA , Dellinger EP , et al: Randomized prospective evaluation of cimetidine and antacid control of gastric pH in the critically ill. Ann Surg 192:169-174, 1980

50.

Martin LF , Max MH , Polk HC : Failure of gastric pH control by antacids or cimetidine in the critically ill: A valid sign of sepsis. Surgery 88:59-68, 1980

51.

Poleski MH , Spanier AH : Cimetidine versus antacids in the prevention of stress erosions in critically ill patients. Am J Gastroenterol 81:107-111, 1986

52.

More DG , Raper RF , Munro IA , et al: Randomized, prospective trial of cimetidine and ranitidine for control of intragastric pH in the critically ill. Surgery 97:215-223, 1985

53.

Reid SR , Bayliff CD : The comparative efficacy of cimetidine and ranitidine in controlling gastric pH in critically ill patients. Can Anaesth Soc J 33:287-293, 1986

54.

Morris DL , Markham SJ , Beechey A. , et al: Ranitidine-bolus or infusion prophylaxis for stress ulcer. Crit Care Med 16:229-232, 1988

55.

McAlhany JC , Czaja AJ , Pruitt BA : Antacid control of complications from acute gastroduodenal disease after burns. J Trauma 16:645-649, 1976

56.

Albin M. , Friedlos J. , Hillman K. : Continuous intragastric pH measurement in the critically ill and treatment with parenteral ranitidine. Int Care Med 11:295-299, 1985

57.

Hauser A. , Quigley ML , Driever CW , et al: More on false-positive "hemoccult" reaction with cimetidine . N Engl J Med 304:847-848, 1981

58.

Layne EA , Mellow MH , Lipman TO : Insensitivity of guaiac slide tests for detection of blood in gastric juice . Ann Intern Med 94:774-776, 1981

59.

Pinilla JC , Oleniuk FH , Reed D. , et al: Does antacid prophylaxis prevent upper gastrointestinal bleeding in critically ill patients? Crit Care Med 13:646-650, 1985

60.

Rosenthal P. , Thompson J. , Singh M. : Detection of occult blood in gastric juice . J Clin Gastroenterol 6:119-121, 1984